Skip to content
Govbase
Govbase
Congress·In Committee·S. 882

Patients Before Middlemen Act

Senate Bill Would Overhaul Medicare Drug Middlemen, Require Full Rebate Pass-Through to Patients

Part of: Pharmacy Benefit Manager (PBM) Reform

Stalled

No legislative action in over 90 days.

Legislative Progress

Senate
House
President
Law

Key Points

  • This bill aims to lower costs and increase pharmacy choices for people on Medicare by changing how 'middlemen,' known as pharmacy benefit managers, are allowed to make money. It requires these companies to be paid flat fees for their services rather than taking a percentage of high drug prices.
  • The policy would require Medicare drug plans to allow any pharmacy to join their network as long as the pharmacy agrees to standard contract terms. This is designed to help independent and local drugstores stay in business and ensure seniors don't have to travel long distances to get their prescriptions.
  • Starting in 2028, drug middlemen would be forced to pass 100% of the rebates and discounts they get from drug makers directly to the insurance plans. This prevents these companies from keeping secret profits that could otherwise be used to lower premiums or out-of-pocket costs for patients.
  • The bill creates special protections for 'essential' pharmacies in rural or underserved areas. The government would track how much these local shops are being paid compared to large mail-order pharmacies owned by the insurance companies to ensure fair treatment.
  • To ensure honesty, the bill gives insurance plans the right to audit their drug middlemen at least once a year. It also allows pharmacies to report unfair contracts to the government without fear of being punished or kicked out of the network.
  • If a drug middleman breaks these rules, they could face expensive government fines. Any illegal profits they made would have to be paid back to the Medicare drug plan.
HealthcareEconomy Finance

Impact Analysis

Personal Impact

Life & Work

Independent pharmacies, many of which are small businesses, stand to benefit significantly. The bill's "any willing pharmacy" rule means drug plans must accept any pharmacy that meets standard terms, preventing PBMs from shutting out local pharmacies in favor of their own mail-order or specialty affiliates. New protections against unfair contract terms, a government complaint process, and anti-retaliation rules give small pharmacy owners leverage they currently lack against powerful PBMs.

4
2
3
5
+4
ImpactCertaintyScopeDurationSentiment

Programs

Disabilities

Milestones

2 milestones2 actions
Mar 6, 2025Senate

Read twice and referred to the Committee on Finance.

Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.

Mar 6, 2025

Introduced in Senate

The bill was officially filed and given a number. It now enters the legislative queue.

Votes

No votes have been recorded for this legislation yet.

Source Information

Document Type

Congressional Bill

Official Title

Patients Before Middlemen Act

Bill NumberS 882
Congress119th Congress
ChamberSenate
Latest ActionRead twice and referred to the Committee on Finance.

Sponsor

Cosponsors

(7)
D: 4R: 3

Political Response

Analysis generated by AI. Always verify with official sources.